{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:15:35Z","timestamp":1782922535361,"version":"3.54.5"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Iron deficiency is the leading cause of anaemia worldwide and is increasingly treated with intravenous (IV) iron therapy. Staining from IV iron therapy is a rare but significant and preventable adverse event. To mitigate patient harm, a health-service-wide quality improvement project was implemented. This study aimed to determine the real-world impact of a quality improvement project on IV iron staining incidents and preventability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective chart audit was undertaken for all IV iron staining episodes reported in a directorate-wide clinical incident reporting database (RiskMan) between 2016 and 2022. Incidence rates of IV iron staining, preventability, and stain severity were compared pre- and post-implementation of a standardized IV iron procedure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over 7 years, 103 IV iron stains were identified, resulting in a staining rate of 0.31 stains per 100 infusions (pre 0.27% and post 0.34%, P\u2009=\u2009.25). Implementation of the standardized IV iron procedure resulted in improvements in pharmacist review of the medication order (61.8% versus 89.7%, P\u2009&amp;lt;\u2009.01), use of the statewide IV iron infusion consent form (27.3% versus 76.9%, P\u2009&amp;lt;\u2009.01), and appropriate cannula site (14.3% versus 52.5%, P\u2009&amp;lt;\u2009.01). Smaller stain sizes were associated with cessation of the infusion at identification of extravasation (312 cm2 versus 35 cm2) (P\u2009=\u2009.04). Preventability was assigned to 86% of stains.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The incidence rate of IV iron staining in a real-world clinical setting is 0.31%. There was increased compliance with several best practice principles and 86% of stains were preventable. Early identification and intervention of potential staining incidents results in smaller iron stains for patients. Quality improvement tools developed for this project can contribute to patient outcomes internationally.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/intqhc\/mzae096","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T14:29:52Z","timestamp":1727447392000},"source":"Crossref","is-referenced-by-count":1,"title":["Intravenous iron staining: real-world incidence, preventability, and mitigation tools from a long-term quality improvement project"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-8728","authenticated-orcid":false,"given":"Martin L","family":"Canning","sequence":"first","affiliation":[{"name":"Clinical Governance, Metro North Hospital and Health Service , Level 14 Block 7, Royal Brisbane and Women\u2019s Hospital, Cnr Butterfield St and Bowen Bridge Road, Herston, QLD 4029,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9269-9397","authenticated-orcid":false,"given":"Jodie B","family":"Hillen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Queensland , UQ Dutton Park, Level 4, 20 Cornwall Street, Woolloongabba, QLD 4102,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Kashiwagi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Queensland , UQ Dutton Park, Level 4, 20 Cornwall Street, Woolloongabba, QLD 4102,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Alizadeh","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Queensland , UQ Dutton Park, Level 4, 20 Cornwall Street, Woolloongabba, QLD 4102,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6429-0316","authenticated-orcid":false,"given":"Christopher R","family":"Freeman","sequence":"additional","affiliation":[{"name":"Clinical Governance, Metro North Hospital and Health Service , Level 14 Block 7, Royal Brisbane and Women\u2019s Hospital, Cnr Butterfield St and Bowen Bridge Road, Herston, QLD 4029,","place":["Australia"]},{"name":"School of Pharmacy, The University of Queensland , UQ Dutton Park, Level 4, 20 Cornwall Street, Woolloongabba, QLD 4102,","place":["Australia"]},{"name":"Faculty of Medicine, The University of Queensland , Level 2, Mayne Medical Building, 288 Herston Road, Herston, QLD 4006,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"2024122707271212900_R1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"2024122707271212900_R2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/ejh.13345","article-title":"The role of iron repletion in adult iron deficiency anemia and other diseases","volume":"104","author":"Elstrott","year":"2020","journal-title":"Eur J Haematol"},{"key":"2024122707271212900_R3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.18773\/austprescr.2020.051","article-title":"A stain on iron therapy","volume":"43","author":"Canning","year":"2020","journal-title":"Aust Prescr"},{"key":"2024122707271212900_R4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jppr.1168","article-title":"Ironing out iron infusions - does premedication reduce adverse reactions during iron polymaltose infusion: a single-centre retrospective review","volume":"46","author":"Chia","year":"2016","journal-title":"J Pharm Pract Res"},{"key":"2024122707271212900_R5","article-title":"Correcting iron deficiency","volume":"39","author":"Baird-Gunning","year":"2016","journal-title":"Austr Prescr"},{"key":"2024122707271212900_R6","article-title":"Statistical Information and Data","author":"Services Australia","year":"2024"},{"key":"2024122707271212900_R7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/jdv.12417","article-title":"Successful treatment with 532-nm Q-switched Nd:YAG laser of cutaneous siderosis following intravenous iron extravasation","volume":"29","author":"Hammami Ghorbel","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024122707271212900_R8","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2024122707271212900_R9","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2024122707271212900_R10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/2040620714521127","article-title":"Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia","volume":"5","author":"Bregman","year":"2014","journal-title":"Ther Adv Hematol"},{"key":"2024122707271212900_R11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/13696998.2022.2158661","article-title":"Estimation of the utilities of attributes of intravenous iron infusion treatment for patients with iron-deficiency anemia: a conjoint analysis in Japan","volume":"26","author":"Takeshima","year":"2023","journal-title":"J Med Econ"},{"key":"2024122707271212900_R12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1108\/IJHCQA-10-2019-0177","article-title":"Preventing skin staining: an effective iron infusion protocol","volume":"33","author":"Crowley","year":"2020","journal-title":"Int J Health Care Qual Assur"},{"key":"2024122707271212900_R13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/jppr2004344293","article-title":"Understanding the medicines management pathway","volume":"34","author":"Stowasser","year":"2004","journal-title":"J Pharm Pract Res"},{"key":"2024122707271212900_R14","article-title":"Model for Improvement & PDSA Cycles","volume-title":"NSW Government","author":"Clinical Excellence Commission"},{"key":"2024122707271212900_R15","article-title":"Intravenous iron therapy (total dose) - Adult patients 004809","author":"Metro North Hospital and Health Service","year":"2022"},{"key":"2024122707271212900_R16","article-title":"Annual Report 2022-23","author":"Metro North Hospital and Health Service","year":"2023"},{"key":"2024122707271212900_R17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15628","article-title":"Extensive skin hyperpigmentation following intravenous iron infusion","volume":"184","author":"Wong","year":"2019","journal-title":"Br J Haematol"},{"key":"2024122707271212900_R18","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2019.80.4.ii","article-title":"Extravasation and pigmentation post iron infusion","volume":"80","author":"El-Zaatari","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"2024122707271212900_R19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-229113","article-title":"Skin staining following intravenous iron infusion","volume":"12","author":"Crowley","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2024122707271212900_R20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.therap.2017.10.005","article-title":"Cutaneous pigmentation related to intravenous iron extravasation: analysis from the French pharmacovigilance database","volume":"73","author":"Hermitte-Gandoliere","year":"2018","journal-title":"Therapie"},{"key":"2024122707271212900_R21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002649","article-title":"A permanent tan from iron","volume":"73","author":"Lim","year":"2008","journal-title":"Kidney Int"},{"key":"2024122707271212900_R22","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231165705","article-title":"Skin staining following intravenous iron extravasation in a patient with chronic kidney disease: a case report","volume":"10","author":"Shi","year":"2023","journal-title":"Can J Kidney Health Dis"},{"key":"2024122707271212900_R23","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000003741","article-title":"Extravasation of intravenous iron causing skin staining in a child with Crohn disease","volume":"76","author":"Paglinco","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024122707271212900_R24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1033486","article-title":"Defining and evaluating the Hawthorne effect in primary care, a systematic review and meta-analysis","volume":"9","author":"Berkhout","year":"2022","journal-title":"Front Med Lausanne"},{"key":"2024122707271212900_R25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intqhc\/mzu098","article-title":"What are incident reports telling us? A comparative study at two Australian hospitals of medication errors identified at audit, detected by staff and reported to an incident system","volume":"27","author":"Westbrook","year":"2015","journal-title":"Int J Qual Health Care"}],"container-title":["International Journal for Quality in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intqhc\/advance-article-pdf\/doi\/10.1093\/intqhc\/mzae096\/59373307\/mzae096.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intqhc\/article-pdf\/36\/4\/mzae096\/61228519\/mzae096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intqhc\/article-pdf\/36\/4\/mzae096\/61228519\/mzae096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T07:27:18Z","timestamp":1735284438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intqhc\/article\/doi\/10.1093\/intqhc\/mzae096\/7780342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10,18]]}},"URL":"https:\/\/doi.org\/10.1093\/intqhc\/mzae096","relation":{},"ISSN":["1353-4505","1464-3677"],"issn-type":[{"value":"1353-4505","type":"print"},{"value":"1464-3677","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,27]]},"article-number":"mzae096"}}